Jonathan Schwarts

Jonathan Schwarts

Company: Rocket Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Joint Q&A Session 12:30 pm

Have the speakers answer your questionsRead more

day: Day One

Autologous HSPC-targeted LV Gene Therapy for Fanconi Anemia & LAD-I: An Update From Rocket Pharmaceuticals 9:00 am

Specific challenges for cell- and gene-based therapy in life-threatening hematopoietic disorders. Fanconi anemia gene therapy program: updated results Leukocyte adhesion deficiency gene therapy program: updated resultsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.